Publication | Closed Access

Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia

Hematological MalignancyOncologyG-csf PrimingMedicineHematologyPharmacotherapyIntensive ChemotherapyPharmacologyAdvanced Myelodysplastic SyndromeCancer ResearchMyeloid Neoplasia